Yonhap Infomax NewsFeb 2
Chong Kun Dang, a major South Korean pharmaceutical firm, saw its 2023 operating profit fall 19% as rising SG&A and R&D costs, along with a negative base effect, offset revenue growth.
#YonhapInfomax #ChongKunDang #OperatingProfit #SGAExpenses #RDCosts #2023Earnings #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=103357
Chong Kun Dang Reports 19% Decline in 2023 Operating Profit—'Higher SG&A and R&D Expenses Drive Negative Base Effect'

Chong Kun Dang, a major South Korean pharmaceutical firm, saw its 2023 operating profit fall 19% as rising SG&A and R&D costs, along with a negative base effect, offset revenue growth.

Yonhap Infomax
Yonhap Infomax NewsDec 4
South Korea’s mid-tier steelmakers are slashing SG&A costs to offset persistently high cost ratios, as cheap Chinese imports and a strong dollar squeeze margins; the new K-Steel Act is expected to offer some relief.
#YonhapInfomax #Steelmakers #CostRatio #SeAHSteelHoldings #KSteelAct #SGAExpenses #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=93876
Mid-Tier Steelmakers Still Struggle With High Cost Ratios—Tightening SG&A Expenses

South Korea’s mid-tier steelmakers are slashing SG&A costs to offset persistently high cost ratios, as cheap Chinese imports and a strong dollar squeeze margins; the new K-Steel Act is expected to offer some relief.

Yonhap Infomax
Yonhap Infomax NewsSep 8, 2025
Korea & Company Group faces surging costs and declining profits amid Chairman Cho Hyun-bum's legal absence, with Hanon Systems' rights offering adding to financial pressures.
#YonhapInfomax #KoreaAndCompany #HanonSystems #SGAExpenses #OperatingProfit #RightsOffering #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=80611
With Chairman Cho Hyun-bum Absent, Korea & Company Group Sees Notable Rise in Costs

Korea & Company Group faces surging costs and declining profits amid Chairman Cho Hyun-bum's legal absence, with Hanon Systems' rights offering adding to financial pressures.

Yonhap Infomax